D003928DisordersC12.777.419.192C13.351.968.419.192C19.246.099.875412460.831282Diabetic Nephropathiesprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonBiochemistryWake Forest School of MedicineCarlLangefeldCarl D. Langefeld PhD36.09550200000000-80.24393700000000149Langefeld, CarlProfessorDonaldBowdenDonald W. Bowden PhD36.09040200000000-80.26700599999999192Bowden, DonaldProfessorLijunMaLijun Ma MD, PhD36.09040200000000-80.26700599999999581Ma, LijunAssociate ProfessorNicholetteAllredNicholette D. Allred PhD36.09040200000000-80.26700599999999706Allred, NicholetteProfessorBarryFreedmanBarry I. Freedman MD36.08959100000000-80.2685990000000078Freedman, BarryProfessor31281543Xiong G, Tang W, Zhang D, He D, Wei G, Atala A, Liang XJ, Bleyer AJ, Bleyer ME, Yu J, Aloi JA, Ma JX, Furdui CM, Zhang YTheranosticsXiong G, Tang W, Zhang D, He D, Wei G, Atala A, Liang XJ, Bleyer AJ, Bleyer ME, Yu J, Aloi JA, Ma JX, Furdui CM, Zhang Y. Impaired Regeneration Potential in Urinary Stem Cells Diagnosed from the Patients with Diabetic Nephropathy. Theranostics. 2019; 9(14):4221-4232.Theranostics2019-05-31T00:00:002019Impaired Regeneration Potential in Urinary Stem Cells Diagnosed from the Patients with Diabetic Nephropathy.30715336Kruzel-Davila E, Divers J, Russell GB, Kra-Oz Z, Cohen MS, Langefeld CD, Ma L, Lyles DS, Hicks PJ, Skorecki KL, Freedman BIThe Journal of clinical endocrinology and metabolismKruzel-Davila E, Divers J, Russell GB, Kra-Oz Z, Cohen MS, Langefeld CD, Ma L, Lyles DS, Hicks PJ, Skorecki KL, Freedman BI. JC Viruria Is Associated With Reduced Risk of Diabetic Kidney Disease. J Clin Endocrinol Metab. 2019 06 01; 104(6):2286-2294.J Clin Endocrinol Metab2019-06-01T00:00:002019JC Viruria Is Associated With Reduced Risk of Diabetic Kidney Disease.32857243Ghoshal S, Allred ND, Freedman BICurrent diabetes reportsGhoshal S, Allred ND, Freedman BI. The Contribution of Kidney Disease to Cognitive Impairment in Patients with Type 2 Diabetes. Curr Diab Rep. 2020 08 28; 20(10):49.Curr Diab Rep2020-08-28T00:00:002020The Contribution of Kidney Disease to Cognitive Impairment in Patients with Type 2 Diabetes.31570541Sedor JR, Freedman BIJournal of the American Society of Nephrology : JASNSedor JR, Freedman BI. Biologic Underpinnings of Type 1 Diabetic Kidney Disease. J Am Soc Nephrol. 2019 Oct; 30(10):1782-1783.J Am Soc Nephrol2019-09-19T00:00:002019Biologic Underpinnings of Type 1 Diabetic Kidney Disease.Internal Medicine, NephrologyPHS-Biostatistics and Data Science (Public Health Sciences)32345960He X, Cheng R, Huang C, Takahashi Y, Yang Y, Benyajati S, Chen Y, Zhang XA, Ma JXSignal transduction and targeted therapyHe X, Cheng R, Huang C, Takahashi Y, Yang Y, Benyajati S, Chen Y, Zhang XA, Ma JX. A novel role of LRP5 in tubulointerstitial fibrosis through activating TGF-ß/Smad signaling. Signal Transduct Target Ther. 2020 Apr 29; 5(1):45.Signal Transduct Target Ther2020-04-29T00:00:002020A novel role of LRP5 in tubulointerstitial fibrosis through activating TGF-ß/Smad signaling.true1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessor14.11610.0080897741research area of0.7843420.0389268113subject area for